Our Science
Revolutionize Rare Disease Care: Hope for Million Patients Worldwide
Unveiling Solutions for Rare Disease Challenges
Did you know that over 300 million people worldwide suffer from rare diseases, often waiting 7-10 years for an accurate diagnosis? Imagine if we could cut this time drastically and provide targeted, life-saving treatments sooner.
The Global Rare Disease Crisis
Rare diseases present a significant healthcare challenge, affecting 300 million people globally, including 30 million Americans and 3 million Canadians. These conditions are notoriously hard to detect and often overlooked, with conventional care frequently misdiagnosing them. As a result, patients endure prolonged diagnostic odysseys, averaging 7-10 years, as per WHO reports. Many remain undiagnosed, suffering from disabilities, poor quality of life, and even death due to the lack of awareness among healthcare providers and inadequacy of conventional technologies.
Overcoming Barriers to Precision Medicine: The Imperative of Timely Biomarker Testing
A critical obstacle in achieving disease-free and personalized medicine is the accessibility of timely biomarker testing. This testing is crucial for targeted prevention, therapies, and treatments. Both laboratories and clinics face challenges in adapting to new biomarkers and technologies, evolving clinical guidelines, and lengthy turnaround times for test results. Conventional care struggles with timely biomarker testing, crucial for personalized medicine and targeted therapies. For example, a recent study on advanced non-small cell lung cancer (NSCLC) highlighted that nearly half of the patients did not benefit from precision medicine due to delays in obtaining biomarker test results.
According to 85% of experts, any diagnosis that can influence management is worth screening for.
U'thumim: Innovative Solutions For Early Detection
Addressing these challenges requires innovative solutions in personalized health security and precision medicine, emphasizing accurate detection, early diagnosis, and efficient treatment pathways. UTHUMIM Health is poised to revolutionize this space with our advanced medical technology devices, laboratory-developed tests (LDTs), and digital health solutions.
Our Vision
Our approach ensures timely and precise diagnosis, improving the lives of those affected by rare diseases.
Our Mission
Empowers targeted prevention, therapies, and treatments, overcoming one of the most significant barriers to disease-free and personalized medicine.
Our Process
We are currently welcoming investments to bring hope and enhanced care to those affected by rare diseases.
Join us in revolutionizing rare disease care
Support UTHUMIM Health’s mission to provide timely and precise diagnoses, transforming the lives of millions. Invest in rare disease ESG and show your support for patients suffering from these conditions.
Invest in rare disease ESG shows your support for patients suffering from these conditions.
